Drug interactions among clinical and psychiatric drugs;Interações farmacológicas entre medicações clínicas e psiquiátricas

Revista de Psiquiatria Clinica

Volumn 31, Issue 2, 2004, Pages 70-81

  Marcolin, Marco Antonio ^a   Cantarelli, Maria Da Graça ^b,c,d   Garcia Jr , Manoel ^b,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c Instituto Abuchaim   (Brazil)

^d HSL PUCRS ^*  (Brazil)

Author keywords

CYP and Cytochrome P450; Drug interaction

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; BROMAZEPAM; CALCIUM CARBONATE; CAPTOPRIL; CARBAMAZEPINE; CEFTRIAXONE; CISAPRIDE; CITALOPRAM; CODEINE; CYTOCHROME P450; DIAZEPAM; FLUOXETINE; FLUVOXAMINE; FUROSEMIDE; HEPARIN; IMIPRAMINE; ISOSORBIDE; METOCLOPRAMIDE; NORTRIPTYLINE; OMEPRAZOLE; OXACILLIN; PARACETAMOL; PAROXETINE; PHENYTOIN; RANITIDINE; SERTRALINE; TRAMADOL; UNINDEXED DRUG; VENLAFAXINE;

ARTICLE; BLEEDING; BRAZIL; DRUG INTERACTION; DRUG METABOLISM; HUMAN; HYPONATREMIA; LIVER TOXICITY; MEDLINE; OPISTHOTONUS; QT PROLONGATION; RASH; TORSADE DES POINTES; UNITED STATES;

EID: 3142697670     PISSN: 01016083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. ABAD-SANTOS, F.; CARCAS, A.J.; CAPITÁN, C.F.; FRIAS, J. - Retroperitoneal Haematoma in a Patient treated with Acenocoumarol, Phenytoin and Paroxetine. Clin Lab Haem 17: 195-7, 1995.
2. ABBOTT, F.S.; KASSAM, J.; ORR, J.M.; FARREL, K.; - The Effect of Aspirin on Valproic acid Metabolism. Clin Pharmacol Ther 40: 94-100, 1986.
3. ALMEIDA, O.P.; RATTO, L.; GARRIDO, R.; TAMAI, S. - Fatores preditores e conseqüências clínicas do uso de múltiplas medicaçõôes em idosos atendidos em um serviço ambulatorial de saúde mental. Rev Bras Psiquiat 21: 152-7, 1999.
4. ANDERSEN, B.B.; MIKKELSEN, M.; VESTERAGER, A.; DAM, M.; KRINTENSEN, H.B.; PEDERSEN, B.; ET AL - No Influence of the Antidepressant Paroxetine on Carbamazepine, Valproate and Phenytoin. Epilepsy Res 10: 201-4, 1991.
5. BANNISTER, S.J.; HOUSER, V.P.; HULSE, J.D.; KISICKI, J.C.; RASMUSSEN, J.G.C. - Evaluation of the Potential for Interactions of Paroxetine with Diazepam, Cimetidine, Warfarin, and Digoxin. Acta Psychatr Scand 80 (supp 350): 102-6, 1989.
6. BOUWER, C.D. (LETTER) - Exacerbation of Respiratory Symptoms in Patients with Panic Disorder. Am J Psychiatry 154: 712-3, 1997.
7. CHANDRAGIRI, S.; PASOL, E.; GALLAGHER, R.M.- Lithium, ACE Inhibitors, NSAIDs, and Verapamil: a Possible Fatal Combination. Psychosomatics; 39: 281-2, 1998.
8. CLAIRE, R.J.; SERVIS, M.E.; CRAM JR., D.L. (LETTER) - Potential Interaction between Warfarin Sodium and FLuoxetine. Am J Psychiatry 148: 1604, 1991.
9. COULTER, D.M.; PILLANS, P.I. - Fluoxetine and Extrapyramidal Side Effects. Am J Psychiatry 152: 122-5, 1995.
10. CUPP, M.J.; TRACY, T.S. - Cytochrome P450: New Nomenclature and Clinical Implications. Clinical Pharmacology 57: 107-116, 1998.
11. DELLA PASCHOA, O.E.; KRUK, M.R.; HAMSTRA, R.; VOSKUIL, R.A.; DANHOF, M. - Pharmacodynamic Interaction between Phenytoin and Sodium Valproate changes Seizure Thresholds and Pattern. British Journal of Phamacology 125: 997-1004, 1998.
12. DENT, L.A.; ORROCK, M.W. - Warfarin-fluoxetine and Diazepam-fluoxetine Interaction. Pharmacotherapy 17: 170-2, 1997.
13. DEVULDER, J.; DE LAAT, M.; DUMOULIN, K.; RENSON, A.; ROLLY, G. - Nightmares and Hallucinations after long-term Intake of Tramadol Combined with Antidepressants. Acta Clinica Belgica 51: 184-6, 1996.
14. DURSUN, S.M.; MATHEW, V.W.; REVELEY, M.A. - Toxic Serotonin Syndrome after Fluoxetine plus Carbamazepine. The Lancet 342: 442-3, 1993.
15. EGBERTS, A.C.G.; TER BORGH, J.; BRODIE-MEIJER, C.C.E. - Serotonin Syndrome Attributed to Tramadol Addiction to Paroxetine Therapy. International Clinical Psychopharmacology 12: 181-2, 1997.
16. EMILIEN, G.; MALOTEAUX, J.M. - Lithium Neurotoxicity at low Therapeutic Doses - Hypotheses for Causes and Mechanism of Actino Following a Retrospective Analysts of Published case Reports. Acta Neurol Belg 96: 281-93, 1996.
17. ERESHEFSKY, L.; RIESENMAN, C.; LAM, Y.W.F. - Antidepressant Drug Interactions and the Cytochrome P450 System. Clin Pharmacokinet 29 (supp 1): 10-9, 1995.
18. FROOMES, P.R.; STEWART, M.R. - A Reversible Parkinsoniana Syndrome and Hepatotoxicity Following Addition of Carbamazepine to Sodium Valproate. Aust NZ J Med 24: 413-4, 1994.
19. GERNAAT, H.B.P.E.; VAN DE WOUDE, J.; TOUW, D.J. - Fluoxetine and Parkinsonism in Patients taking Carbamazepine. Am J Psychiatry 148: 11, 1991.
20. GIDAL, B.E.; ANDERSON, G.D.; SEATON, T.L.; MIYOSCHI, H.R.; WILENKSY, A.J. - Evaluation of the EFfect of Fluoxetine on the Formation of Carbamazepine Epoxide. Therapeutic Drug Monitoring 15: 405-9, 1993.
21. GIUSTI, P.; BURIANI, A.; CIMA, L.; LIPARTITI, M. - Effect of Acute and Chronic Tramadol on [3H]-5-HT uptake in rat Cortical Synaptosomes. British Journal of Pharmacology 122: 303-6, 1997.
22. GRIMSLEY, S.R.; JANN, M.W.; CARTER, G.; D'MELLO, A.; D'SOUZA, M.J. - Increased Carbamazepine Plasma Concentrations after Fluoxetine Coadministration. Clin Pharmacol Therapeutics 50: 10-5, 1991.
23. GRUCHALA, R. - Clinical Assessment of Drug Induced Disease. Lancet 356: 1505-11, 2000.
24. a ed., 1996.
25. JALIL, P. (LETTER) - Toxic Reaction Following the Combined Administration of FLuoxetine and Phenytoin: two case Reports. J Neurol Neurosurg and Psych 55: 412-3, 1992.
26. JANICACK, P.G. - The Relevance of Clinical Pharmacokinetics and Therapeutic Drug Monitoring: Anticonvulsant Mood Stabilizers and Antipsychotics. J Clin Psychiatry 54 (supp 9): 35-41, 1993a.
27. JOHNSON, A.G.; SEIDEMAN, P.; DAY, R.O. - Adverse Drug Interactions with Nonsteroidal Anti-inflammatory Drugs (NSAIDs). Drug Safety 8: 99-127, 1993.
28. JOHNSON, M.D.; NEWKIRK, G.; WHITE JR. - Clinically Significant Drug Interactions. Postgraduate Medicine 105: 193-222, 1999.
29. LAI, M.; HUANG, J. - Dual Effect of Valproic acid on the Pharmacokinetics of Phenytoin. Biopharmaceutics and Drug Disposition 14: 365-70, 1993.
30. LAMBERT, M.T.; TRUTIA, C.; PETTY, F. - Extrapyramidal Adverse Effects Associated with Sertralina. Prog Neuro-Psychopharmacol and Biol Psychiat 22: 741-8, 1998.
31. LANE R.M. (LETTER) - Carbamazepine and Sertralina. New Zealand Medical Journal 107: 209, 1994.
32. LANE R.M. - SSRIs and Hyponatraemia. BJCP 51: 144-6, 1997.
33. LAZAROU, J.; POMERANZ, B.H.; COREY, P.N. - Incidence of Adverse Drug Reactions in Hospitalized Patients. JAMA 279: 1200-5, 1998.
34. LEANDER, J.D. - Fluoxetine, a Selective Serotonin-uptake Inhibitor, Enhances the Anticonvulsant Effects of Phenytoin, Carbamazepine, and Ameltolide (LY201116). Epilepsia 33: 573-6, 1992.
35. LEMBERG, L.; ROWE, H.; BOSOMWORTH, J.C.; TENBARGE, J.B.; BERGSTROM, R.F. - The Effects of Fluoxetine on the Pharmacokinetics and Psychomotor Responses of Diazepam. Clin Pharmacol Ther 43: 412-9, 1988.
36. LEVY, R.H. - Cytochrome P450 Isozymes and Antiepileptic Drug Interactions. Epilepsia 36 (supp 5): S8-S13, 1995.
37. LIU, H., DELGADO M. - Interactions of Phenobarbital and Phenytoin with Carbamazepine and its Metabolites Concentrations, Concentration Ratios, and Level/dose Ratios in Epileptic Children. Epilepsia 36: 249-54, 1995.
38. LLORENTE, M.D.; GORELICK, M.; SILVERMAN, M.A. - Sertraline as the Cause of Inappropriate Antidiuretic Hormone Secretion. J Clin Psychiatry 55: 543-4, 1994.
39. MADSEN H., ENGGAARD T.P., HANSEN L.L., KLITGAARD N.A., BRØSEN, K. - Fluvoxamine Inhibits the CYP2C9 Catalyzed Biotransformation of Tolbutamide. Clin Pharmacol Ther 69: 41-7, 2001.
40. MAMIYA K., KOJIMA, K., YUKAWA E., HIGUCHI, S., IERI, I., NINOMIYA H., ET AL - Phenytoin Intoxication induced by Fluvoxamine. Therapeutic Drug Monitoring 23: 75-7, 2001.
41. MANTO, M.U.; JACQUY, J.; HILDEBRAND, J. - Cerebellar Ataxia in upper Limbs Triggered by Addition of Carbamazepine to Lithium Treatment. Acta Neurol Belg 96: 316-7, 1996.
42. MARAR, I.E.; TOWERS, A.L.; MULSANT, B.H.; POLLOCK, B.G.; AMICO, J.A. - Effect of Paroxetine on Plasma Vasopressina and Water load Testing in Elderly Individuals. J Geriatr Psychiatry Neurol 13: 212-6, 2000.
43. MARCOLIN, M.a - Interações Farmacológicas com Drogas Psiquiátricas. MEDSI; 1998. 408p.
44. MARTINEZ, C.; ALBERT, C.; AGÚNDEZ, J.A.G.; HERRERO, E.; CARRILLO, J.A.; MÁRQUEZ, M.; ET AL - Comparative in vitro and in vivo Inhibition of Cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor Antagonists. Clin Pharmacol Ther 65: 369-76, 1999.
45. MASON, B.J.; BLACKBURN, K.H. - Possible Serotonin Syndrome Associated with Tramadol and Sertraline Coadministration. The Annals of Pharmacotherapy 31: 175-7, 1997.
46. MCKEE, P.J.W.; BLACKLAW, J.; BUTLER, E.; GILLHAM, R.A.; BRODIE, M.J. - Valiability and Clinical Relevance of the Interaction between Sodium Valproate and Carbamazepine in Epileptic Patients. Epilepsy Res 11: 193-8, 1992.
47. MITCHELL, P.B. - Drug Interactions of Clinical Significance with Selective Serotonin Reuptake Inhibitors. Drug Safety 17: 390-406, 1997.
48. MIYASAKA, L.S.; ATALLAH, A.N. - Risk of drug Interactions: Combination of Antidepressants and other Drug. Rev Saúde Pública 37: 212-5, 2003.
49. MONSTRATUC, J.L.; LLAU, M.E.; RASCOL, °; SENARD, J.M. - Drug-induced Parkinsonismo: a Review. Fundam Clin Pharmacol 8: 293-306, 1994.
50. PATSALOS, P.N.; FRÖSCHER, W.; PISANI, F.; VAN RIJN, C.M. - The Importance of drug Interactions in Epilepsy Therapy. Epilepsia 43: 365-85, 2002.
51. PATSALOS, P.N.; PERUCCA, E. - Clinically Important Drug Interactions in Epilepsy: General Features and Interactions between Antiepileptic Drugs. Lancet Neurology 2: 347-56, 2003.
52. PEARSON, H.J. (LETTER) - Interaction of Fluoxetine with Carbamazepine. J Clin Psychiatry 51: 126, 1990.
53. PIRES, J.G.P.; FONSECA, F.C.G.; WOELFFEL, A.B.; FUTURO-NETO, H.A. - Evidence of Interaction between Fluoxetine and Isosorbide Dinitrate on Neuroleptic-induced CAtalepsy in mice. Brazilian Journal of Medical and Biological Research 31: 417-20, 1998
54. PISANI, F. - Influence of Co-medication on the Metabolism of Valproate. Pharm Weekbl 14: 108-13, 1992.
55. PRESKORN, S. - Clinically Relevant Pharmacology of Selective Serotonin Reuptake Inhibitors: an Overview with Emphasis on Pharmacokinetics and Effects on Oxidative Drug Metabolism. Clin Pharmacokinet 32 (supp 1): 1-21, 1997.
56. QUINN, D.I.; DAY, R.O. - Drug Interactions of Clinical Importance: an Updated Guide. Drug Saf 12: 393-452, 1995.
57. RICHELSON, E. - Pharmacokinetic Drug Interactions of new Antidepressants: a Review of the Effects on the Metabolism of other Drugs. Mayo Clin Proc 72: 835-47, 1997.
58. RICHELSON, E. - Pharmacokinetic Interactions of Antidepressants. J Clin Psychiatry 59 (supp 10): 22-6, 1998.
59. SAFFER, D.; COPPEN, A. - Furosemide: a Safe Diuretic during Lithium Therapy? J Affective Disord 5: 289-92, 1983.
60. SCHIMIDER, J.; GREENBLATT, D.J.; VON MOLTKE, L.L.; KARSOV, D.; SHADER, R. - Inhibition of CYP2C9 by Selective Serotonin Reuptake Inhibitors in vitro: Studies of Phenytoin p-hydroxylation. Br J Clin Pharmacol 44: 495-8, 1997.
61. SHAD, M.U.; HARVEY, A.T.; LUCOT, J.B. (LETTER) - A Possible Pharmacokinetic Interaction between Fluoxetine and Acetylsalicylic acid. J Clin Psychiatry 58: 549-50, 1997.
62. SHADER, R.I.; GREENBLATT, D.J.; VON MOLTKE, L.L. (EDITORIAL) - Fluoxetine Inhibition of Phenytoin Metabolism. Journal of Clinical Psychopharmacology 14: 375-6, 1994.
63. SPINA, E., AVENOSO, A.; CAMPO, G.M. - The Effect of Carbamazepine on the 2-Hydroxylation of Desipramine. Psychopharmacology Berl 117: 413-6, 1995.
64. SPINA, E.; PISANI, F.; PERUCCA, E. - Clinically Significant Pharmacokinetic Drug Interactions with Carbamazepine. Clin Pharmacokinet 31: 198-214, 1996.
65. STECKLER, T.L. - Lithium and Carbamazepine-associated Sinus Node Dysfunction: Nine-year Experience in a Psychiatric Hospital. J Clin Pharmacol 14: 336-9, 1994.
66. STEFFENS, D.C.; KRISHNAN, K.R.R. - Metabolism, Bioavailability, and Drug Interactions. Clinics in Geriatric Medicine 14: 17-31, 1998.
67. SUCAR, D.D. - Interação medicamentosa de venlafaxina com captopril. Rev Bras de Psiq 22: 134-7, 2000.
68. THASE, M.E. - Effects of Venlafaxine on Blood Pressure: a Meta-analysis of Original data from 3744 Depressed Patients. J Clin Psychiatry 59: 502-8, 1998.
69. THOMAS, A.R.; CHAN, L-N.; BAUMAN, J.L.; OLOPADE, C.O. - Prolongation of the QT Interval related to Cisaprida-diltiazem Interaction. Pharmacoterapy 18: 381-5, 1998.
70. THUMMEL, K.E.; LEE, C.A.; NELSON, S.D.; SLATERRY, J.T. - Oxidation of Acetaminophen to N-acetyl-p-aminobenzoquinone imine by Human CYP3A4. Biochemical Pharmacology 45: 1563-9, 1993.
71. TUNE, L.; BYLSMA, F.W.; HILT, D.C. - Anticholinergic Delirium caused by Topical Homatropine Ophthalmologic Solution: Confirmation by Anticholinergic Radioreceptor Assay in two cases. J Neuropsychiatry 4: 195-7, 1992.
72. VAN HARTEN, J.; HOLLAND, R.L.; WESNES, K. - Influence of Multiple-dose Administration of Fluvoxamine on the Pharmacokinetics of the Benzodiazepines Bromazepan and Lorazepan: a Randomized Cross-over Study. Eur Neuropsychopharmacol 2: 381-7, 1992.
73. VERME-GIBBONEY, C. - Oral Angiotensin-converting-enzyme Inhibitors. Am J Health-Syst Pharm 54: 2689-703, 1997.
74. VISKIN, S. - Long QT Syndromes and Torsades de pointes. The Lancet 354: 1625-33, 1999.
75. WAGER, E.; TOOLEY, P.J.H.; PEARCE, G.L.; WILTON, L.V.; MANN, R.D. - A Comparison of two Cohort Studies Evaluating the Safety of Cisapride: Prescription-event Monitoring and a large Phase IV Study. Eur J Clin Pharmacol 52: 87-94, 1997.
76. WALKER, A.M.; SZENEKE, P.; WEATHERBY, L.B.; DICKER, L.W.; LANZA, L.L.; LOUGHLIN, J.E.; YEE, C.L.; DREYER, N.A. - The Risk of Serious Cardiac Arrhythmias among Cisapride users in the United Kingdom and Canada. Am J Med 107: 356-62, 1999.
77. WANG, S.; LAI, M.; HUANG, J. - Increased Microsomal Irreversible Binding of Phenytoin by Valproic acid. Biochemical Pharmacology 42: 1143-4, 1991.
78. WILSON, L.B.; WOODWARD, A.M.; FERRARA, J.J. - An acute Dystonic Reaction with long-term use of Ranitidine in an Intensive care unit Patient. J LA State Med Soc 149: 36-8, 1997.
79. WILTINK, E.H. - Medication Control in Hospitals: a Practical Approach to the Problem of Drug-drug Interactions. Pharm World Sci 20: 173-7, 1998.
80. WONG SHE, E.N.; BLACK, P. - Confusion and Hyponatraemia in a Patient treated with Fluoxetina. New Ethicals November 65-6, 1996.
81. WOODS, D.J.; COULTER, D.M.; PILLANS, P. (LETTER) - Interaction of Phenytoin and Fluoxetine. New Zealand Medical Journal 107: 19, 1994.
82. WYNN, R.L. - Dental Nonsteroidal Anti-inflammatory Drugs and Prostaglandin-based drug Interactions, part two. General Destistry march: 104-10, 1992.
83. YOUNG, C.R.; MAZURE, C. - Fulminant Hepatic Failury from Acetaminophen in an Anorexic Patient treated with Carbamazepine. J Clin Psychiatry 59: 622, 1998.
84. YUE, Q.T.; TOMSON, T.; SAWE, J. - Carbamazepine and Cigarette Smoking induce Differentially the Metabolism of Codeine in Man. Pharmacogenetics 4: 193-8, 1994.
85. YUKAWA, E.; HONDA, T.; OHDO, S.; HIGUCHI, S.; AOYAMA, T. - Detection of Carbamazepine-induced Changes in Valproic acid Relative Clearance in Man by Simple Pharmacokinetic Screening. J Pharm Pharmacol 49: 751-6, 1997.
86. ZHAO, Q.; WOJCIK, M.A.; PARIER, J.L.; PESCO-KOPLOWITZ, L. - Influence of Coadministration of Fluoxetine on Cisapride Pharmacokinetics and QTc Intervals in Healthy Volunteers. Pharmacotherapy 21: 149-57, 2001.